but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication.
Wake Forest, NC (PRWEB) December 23, 2008
Parrish Medical Center has selected Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics.
Parrish Medical Center (PMC) is a publicly owned, not-for-profit hospital with 210 beds, providing care to the residents of North Brevard and surrounding communities. Providing healing experiences to everyone all the time is PMC's highest mission. PMC delivers personalized care and health-related services consistent with the highest quality medical and ethical standards to improve the health status of the people they serve.
The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure network to an accredited reading center. "By introducing the Retasure system to the Parrish Community Clinic, we are able to greatly improve our retinal assessment rates for our diabetic patients who may not have access to an eye doctor. This technology allows us to perform the eye test conveniently and cost effectively. By picking up eye disease earlier, we can then can refer them for proper treatment and improve their outcomes,"
states Dr. Christopher Manion, Network Medical Director of Parrish's Community Health Network.
Scott Sanner, Senior Vice President of North American Operations for Digital Healthcare agrees. "Retasure ™ in the primary care setting improves the chances of prevention of unnecessary sight loss. The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."
Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; and it obtains exceptionally high-quality digital images of the retina. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups.
For additional information, please visit http://www.retasure.com
CONTACT: Scott Sanner (866) 539-4213